The drug discovery startup, co-founded by research technology producer Atomwise, has pulled in $14.5m through a round led by DCVC Bio.
X-37, a US-based drug discovery company co-founded by biotech research technology producer Atomwise, has closed a $14.5m series A round led by DCVC Bio, a fund operated by venture capital firm Data Collective. DCVC Bio was joined in the round by VC funds Alpha Intelligence Capital and Hemi Ventures. Founded in 2018, X-37 is working…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.